安哥拉引入PCV13四年后4-12岁儿童肺炎链球菌携带研究
本研究在安哥拉罗安达和绍里木开展横断面鼻咽部携带研究,纳入940名4-12岁儿童,评估PCV13引入四年后肺炎链球菌血清型分布及抗菌药物敏感性。肺炎链球菌定植率为35%,其中41%的血清型被PCV13覆盖;青霉素不敏感率为40%,PCV13包含血清型中为50%。阿莫西林对多数肺炎链球菌和流感嗜血杆菌敏感(分别为99%和88%)。
要点
- 4-12岁儿童肺炎链球菌定植率为35%(95%CI 32-39%),PCV13覆盖41%的血清型。
- 常见血清型为3、18C、23F、11A、34、19F和16型。
- 青霉素不敏感率为40%,PCV13包含血清型中为50%;阿莫西林敏感性高(99%)。
核心结论
- PCV13在未接种年龄组中疫苗血清型携带常见,持续使用可能产生直接和群体效应。
- 阿莫西林可作为安哥拉呼吸道感染的经验性治疗选择。
研究设计与样本
- 2017年11月至12月在安哥拉罗安达和绍里木开展的横断面鼻咽部携带研究,纳入940名4-12岁儿童。
- 罗安达和绍里木的PCV13第三剂覆盖率分别为67%和84%。
主要发现
- 肺炎链球菌定植率为35%(95%CI 32-39%,n=332),PCV13覆盖41%的血清型。
- 最常见血清型为3(8%)、18C(6%)、23F(6%)、11A(6%)、34(6%)、19F(5%)和16(5%)。
- 流感嗜血杆菌和卡他莫拉菌携带率分别为13%(95%CI 11-15%)和15%(95%CI 13-17%)。
- 肺炎链球菌对青霉素不敏感率为40%,PCV13包含血清型中为50%(vs 33%,p=0.003),中位MIC为0.19 µg/mL(IQR 0.13-0.25 µg/mL)。
- 肺炎链球菌和流感嗜血杆菌对阿莫西林敏感率分别为99%和88%;三种菌对甲氧苄啶-磺胺甲噁唑耐药率均>70%。
临床怎么用
- 持续使用PCV13可能对安哥拉肺炎链球菌感染产生直接和群体效应。
- 阿莫西林可作为安哥拉呼吸道感染的经验性治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children in Angola are affected by a high burden of disease caused by pneumococcal infections. The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the childhood immunization programme in 2013 but the serotype distribution of Streptococcus pneumoniae and antimicrobial susceptibility patterns are unknown. We did a cross-sectional nasopharyngeal carriage study in Luanda and Saurimo, Angola (PCV13 3rd dose coverage 67% and 84%, respectively) during November to December 2017 comprising 940 children aged 4-12 years. The main objective was to assess vaccine serotype coverage and antimicrobial susceptibility rates for S. pneumoniae. Our secondary aim was to characterize colonizinig strains of Haemophilus influenzae and Moraxella catarrhalis. Pneumococcal colonization was found in 35% (95% CI 32-39%) of children (n = 332), with 41% of serotypes covered by PCV13. The most common serotypes were 3 (8%), 18C (6%), 23F (6%), 11A (6%), 34 (6%), 19F (5%) and 16 (5%). Carriage of H. influenzae and M. catarrhalis was detected in 13% (95% CI 11-15%) and 15% (95% CI 13-17%) of children, respectively. Non-susceptibility to penicillin was common among pneumococci (40%), particularly among PCV13-included serotypes (50% vs. 33%; p = 0.003), although the median minimal inhibitory concentration was low (0.19 µg/mL, IQR 0.13-0.25 µg/mL). Most pneumococci and H. influenzae were susceptible to amoxicillin (99% and 88%, respectively). Furthermore, resistance to trimethoprim-sulfamethoxazole was>70% among all three species. Multidrug-resistant pneumococci (non-susceptible to ≥ 3 antibiotics; 7% [n = 24]) were further studied with whole genome sequencing to investigate clonality as an underlying cause for this phenotype. No clearly dominating clone(s) were, however, detected. The results indicate that continued use of PCV13 may have positive direct and herd effects on pneumococcal infections in Angola as carriage of vaccine serotypes was common in the non-vaccinated age group. Finally, amoxicillin is assessed to be a feasible empirical treatment of respiratory tract infections in Angola.
引用
- Uddén F, Filipe M, Slotved HC, et al. Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine. Vaccine. 2020. PMID: 33143954. doi:10.1016/j.vaccine.2020.10.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。